Marengo Asia Healthcare is in talks to raise ₹400-500 crore through a minority stake sale to LeapFrog Investments, the International Finance Corporation (IFC), and the National Investment and Infrastructure Fund (NIIF), according to livemint.com. The hospital platform, backed by Samara Capital and family offices of the Havells and Godrej groups, aims to use the funds to support its growth plans.
The discussions involve these investors acquiring a minority stake in Marengo Asia Healthcare, which reported ₹468 crore in revenue in the first half of FY26. The capital infusion is expected to fuel Marengo’s next phase of expansion, including inorganic growth strategies and increasing capacity at its Gurgaon and Faridabad facilities, livemint.com reported.
This funding round highlights growing investor interest in healthcare infrastructure in India, a sector witnessing rapid expansion amid rising demand for quality medical services. Comparable deals in the healthcare space have attracted significant capital as companies scale operations to meet patient needs and improve service delivery. The involvement of global and domestic institutional investors underscores confidence in Marengo’s business model and growth potential.
Marengo Asia Healthcare plans to deploy the proceeds to accelerate its expansion, focusing on both organic and inorganic growth. The company is expected to enhance its existing hospital capacities and explore acquisition opportunities to strengthen its presence in key markets, according to livemint.com. Observers will watch for the deal’s closure and subsequent developments in Marengo’s expansion strategy.